Phone: (973) 315-4412
Fax: (973) 379-7734
amiller@budd-larner.com
|
Andrew J. Miller
Shareholder
Andrew Miller is the head of the firm's Intellectual Property Group. Mr. Miller handles litigation and complex corporate business arrangements, most often in the pharmaceutical industry. He served as General Counsel for a generic pharmaceutical company and has a deep understanding of the legal issues in that industry. Mr. Miller also served as an Assistant United States Attorney litigating disputes for federal agencies, including the FDA. He has litigated numerous Hatch-Waxman (ANDA) cases as well as a variety of other matters in the pharmaceutical industry ranging from complex business torts to trademark, trade secret and contract actions. He also frequently represents pharmaceutical companies in corporate transactions ranging from supply agreements to complex licensing and joint venture arrangements.
Education
-
University of Buffalo
B.A.
,
1977
summa cum laude
-
University of Michigan Law School
J.D.
,
1980
- Editor, Michigan Journal of Law Reform
Bar Admission
- New York, 1981
- U.S. District Court, Southern and Eastern Districts of New York, 1981
- U.S. Court of Appeals, Second Circuit, 1982
- New Jersey, 1983
- U.S. District Court, District of New Jersey, 1983
- U.S. Court of Appeals, Third Circuit, 1998
- U.S. Court of Appeals, Federal Circuit, 2000
Practice Areas
- Intellectual Property Litigation
- Corporate Transactions
- Commercial Litigation
Professional Profile
- Former General Counsel, Dr. Reddy's Laboratories
- Former Assistant United States Attorney, District of New Jersey
- Member: American Bar Association (Member, Patent, Trademark & Copyright Law Section)
- Member: New York and New Jersey State Bar Associations
Articles/Publications
-
A Proposed Amendment to Rule 26(b)(4)(B): The Expert Twice Retained, 12 University of Michigan Journal of Law Reform 533
Honors/Awards
- Asialaw In-house General Counsel Award, 2005.
- Selected for inclusion in The Best Lawyers in America, Intellectual Property Law, 2006 to date.
Speaking Engagements
- Generic Drugs Summit, September 2003, "Hatch-Waxman Reform - Rule Change or Legislative Fix."
- National South Asian Bar Association, June 2004, "Paragraph IV Litigation: An Indian Company Perspective."
- Pharmaceutical Antitrust Summit, April 2007, "Settling Pharmaceutical Patent Disputes."
- Licensing Executives Society, October 2007, "Early Access Agreements In Pharma."
- Pharmaceutical Antitrust Summit, April 2008, "Settling Pharmaceutical Patent Disputes."
- Montclair State University School of Business, Advanced Legal Management Program, November 2009, "What Successful Leaders Do."
|
